Login
Annotated Medicine and Device Lists
Home
Annotated Medicine and Device Lists
PAHO Strategic Fund Medicine List
/ Ombitasvir + paritaprevir + ritonavir
Ombitasvir + paritaprevir + ritonavir
Tablet
12.5 mg + 75 mg + 50 mg.
This medicine is present in:
List
Section
Observation
WHO Model List of Essential Medicines (2021)
6.4.4.2.2 Non-pangenotypic direct-acting antiviral combinations
No observations
PAHO Strategic Fund Medicine List
2.6.4.2. Medicines for Hepatitis C
No observations
Information Resources:
Ombitasvir + paritaprevir + ritonavir
Scientific Production
Evaluation Reports
Marketed Drugs
Medicine Evidences Summaries
Loading ...
Loading ...
Loading ...
No information available